# Maximus, Inc.: Form 10-Q for the period ended Dec 31, 2016

- Company: [Maximus, Inc.](/companies/mms.md) (CIK 1032220)
- Form: 10-Q
- Filed: 2017-02-09
- Accepted by EDGAR: Feb 9, 2017, 17:11 ET
- Period: 2016-12-31
- Accession: 0001032220-17-000007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1032220/000103222017000007/mms-2016x12x31x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1032220/000103222017000007/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2016-10-01 to 2016-12-31 | $607.6m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2016-10-01 to 2016-12-31 | $462.7m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2016-10-01 to 2016-12-31 | $144.8m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2016-10-01 to 2016-12-31 | $65.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2016-10-01 to 2016-12-31 | $73.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2016-10-01 to 2016-12-31 | $849.0k | us-gaap:InterestExpense |
| Income tax | 3 months, 2016-10-01 to 2016-12-31 | $26.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2016-10-01 to 2016-12-31 | $46.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2016-10-01 to 2016-12-31 | $0.71 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2016-10-01 to 2016-12-31 | $0.71 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2016-10-01 to 2016-12-31 | 66,020,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2016-10-01 to 2016-12-31 | $71.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 3 months, 2016-10-01 to 2016-12-31 | $28.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2016-12-31 | $69.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2016-12-31 | $587.5m | us-gaap:AssetsCurrent |
| Total assets | at 2016-12-31 | $1.30bn | us-gaap:Assets |
| Current liabilities | at 2016-12-31 | $289.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2016-12-31 | $534.0m | us-gaap:Liabilities |
| Long-term debt | at 2016-12-31 | $150.3m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2016-12-31 | $240.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2016-12-31 | $759.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 29,375 characters.

*The following discussion and analysis of financial condition and results of operations is provided to enhance the understanding of, and should be read in conjunction with, our Consolidated Financial Statements and related Notes included both herein and in our Annual Report on Form 10-K for the year ended September 30, 2016, which was filed with the Securities and Exchange Commission on November 21, 2016.*

### Business Overview

We are a leading operator of government health and human services programs worldwide. We act as a partner to governments under our founding mission of *Helping Government Serve the People.®* We use our experience, business process management expertise and advanced technological solutions to help government agencies run effective, efficient and accountable programs.

Over the past five years, our business has reported significant organic growth. We believe this growth has been driven by economic and demographic factors, such as aging populations and increased demand for health care, and political factors, such as health care reform in the United States and welfare reform in Australia and the United Kingdom. In addition, we have acquired businesses that have provided us opportunities to expand our skills, technology and customer relationships to complement our existing business and provide opportunities for further organic growth.

We believe that governments will continue to seek opportunities to enhance existing processes or address new challenges through companies such as MAXIMUS. The environment is dynamic with many emerging political and economic changes, including the transition to the new administration in the United States and Brexit in the United Kingdom. Nevertheless, the long-term, macro-economic drivers of rising caseloads and increasing demand for effective government programs remain unchanged. We have witnessed common themes emerge across all of our markets as governments tackle changing demographics, decentralization initiatives, and the need to get value for government spend. Periods of change are often beneficial to us as governments seek trusted partners to help them operationalize new ideas and implement new or changing policies.

As governments look to identify and reward providers based upon results, we see opportunities to expand based upon our innovative technology, deep subject matter expertise, stringent adherence to our Standards of Business Conduct and Ethics, robust financial performance and worldwide experience. Further, MAXIMUS is one of the largest commercial service providers to government that is completely conflict-free. We have no financial affiliation with any health plans and providers, service providers or outside entities that could in any way impact or influence our ability to provide objective services to governments and the people they serve.

During fiscal year 2016, we acquired Ascend Management Innovations, LLC (Ascend) and three companies doing business as “Assessments Australia." These businesses were integrated into our Health Services and Human Services Segments, respectively. We believe that both acquisitions will allow us to expand our service offerings.

### Financial Overview

Our results for the three months ended December 31, 2016 were driven by the following:

- Revenue growth over the same period in fiscal year 2016 from the expansion of contracts, particularly within the Health Services Segment;
- Profitability improvements across our segments as a result of cost management and business optimization initiatives, particularly within the U.S. Federal Services Segment;
- The benefit from our acquisition of Ascend in February 2016;
- The detrimental effects of the decline in the value of the British Pound, which reduced revenue and profit in both the Health Services and Human Services Segments; and
- The restructuring of our Human Services operations in the United Kingdom, as part of the ongoing integration efforts of Remploy, which has resulted in severance and contract termination charges in this period.

### Results of Operations

#### Consolidated

The following table sets forth, for the periods indicated, selected statements of operations data:

*(dollars in thousands, except per share data)*

|  | Three Months Ended December 31, 2016 | 2015 |
| --- | ---: | ---: |
| Revenue | $607,564 | $556,722 |
| Cost of revenue | 462,746 | 446,507 |
| Gross profit | 144,818 | 110,215 |
| Gross profit percentage | 23.8% | 19.8% |
| Selling, general and administrative expenses | 65,398 | 64,234 |
| Selling, general and administrative expense as a percentage of revenue | 10.8% | 11.5% |
| Amortization of intangible assets | 3,402 | 3,149 |
| Restructuring costs | 2,242 | — |
| Acquisition-related expenses | — | 46 |
| Operating income | 73,776 | 42,786 |
| Operating margin | 12.1% | 7.7% |
| Interest expense | 849 | 989 |
| Other income, net | 263 | 1,131 |
| Income before income taxes | 73,190 | 42,928 |
| Provision for income taxes | 26,861 | 16,046 |
| Effective tax rate | 36.7% | 37.4% |
| Net income | 46,329 | 26,882 |
| Income/(loss) attributable to noncontrolling interests | (335) | 273 |
| Net income attributable to MAXIMUS | $46,664 | $26,609 |
| Basic earnings per share attributable to MAXIMUS | $0.71 | $0.40 |
| Diluted earnings per share attributable to MAXIMUS | $0.71 | $0.40 |

As our business segments have different factors driving revenue growth and profitability, the sections that follow cover these segments in greater detail.

Changes in revenue, cost of revenue and gross profit for the three months ended December 31, 2016 are summarized below.

*(dollars in thousands)*

|  | Revenue Dollars | Percentage change | Cost of Revenue Dollars | Percentage change | Gross Profit Dollars | Percentage change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Balance for respective period in fiscal year 2016 | $556,722 |  | $446,507 |  | $110,215 |  |
| Organic growth | 60,187 | 10.8% | 24,777 | 5.5% | 35,410 | 32.1% |
| Acquired growth | 6,379 | 1.1% | 5,570 | 1.2% | 809 | 0.7% |
| Currency effect compared to the prior period | (15,724) | (2.8)% | (14,108) | (3.2)% | (1,616) | (1.5)% |
| Balance for respective period in fiscal year 2017 | $607,564 | 9.1% | $462,746 | 3.6% | $144,818 | 31.4% |

13

Revenue for the three months ended December 31, 2016 increased 9.1%, respectively, compared to the same period in fiscal year 2016. Much of this growth was organic growth from our Health Services Segment.

For the three months ended December 31, 2015, revenue and profit were unfavorably impacted by the delay of a $8.6 million change order in our Health Services Segment. While working 'at risk', we incurred costs to perform the work but did not recognize the revenue until the contract amendment was executed. If this contract amendment had been executed prior to December 31, 2015, revenue in the first quarter of fiscal 2016 would have been $8.6 million higher, gross and operating profit margins would have been 21% and 9.1% respectively and our diluted earnings per share would have been higher by $0.08.

Cost of revenue for the three months ended December 31, 2016 increased 3.6% compared to the same period in fiscal year 2016. Cost of revenue consists of direct costs related to labor, subcontractor labor, outside vendors, rent and other direct costs. Although movements in cost typically correlate with revenue growth, we experienced operating efficiencies in this quarter, notably within the U.S. Federal Services Segment, as well as the revenue benefit, with no corresponding incremental costs, from the "at risk" contract noted above.

Gross profit for the three months ended December 31, 2016 increased 31% compared to the same period in fiscal year 2016. Our gross profit margin was 23.8%, compared to 19.8% in the same period in fiscal year 2016.

Selling, general and administrative expense (SG&A) for the three month periods ended December 31, 2016 increased 1.8% compared to the same period in fiscal year 2016. These costs do not include the United Kingdom restructuring costs of $2.2 million noted below. SG&A consists of indirect costs related to general management, marketing and administration. It is primarily composed of labor costs. These costs may be incurred at a segment level, for dedicated resources that are not client-facing, or at a corporate level. Corporate costs are allocated to segments on a consistent, rational basis. Fluctuations in our SG&A are driven by changes in our administrative cost base, which is not directly driven by changes in our revenue.

During the three months ended December 31, 2016, we undertook a restructuring of our United Kingdom Human Services operations as part of the ongoing integration of Remploy. We recorded restructuring costs of $2.2 million, including severance of $2.0 million and lease termination expenses of $0.2 million. Some smaller charges will occur in future quarters. This restructuring is expected to result in cost savings in future periods. Remploy is partially owned by its employees and, accordingly, some of this charge is offset through the loss attributable to noncontrolling interests.

Our interest expense is driven by borrowings from our credit facility. We use derivatives to limit our exposure to interest rate fluctuations. At December 31, 2016, we had a fixed interest rate swap covering $28.0 million of outstanding debt. In January 2017, we entered into a further interest rate swap to cover an additional $20.0 million. Both interest rate swaps will expire before the end of fiscal year 2017.

Our other income is typically provided through interest income from our foreign cash balances. During fiscal year 2016, we also received the benefit of a foreign exchange gain that is not expected to recur.

Our year-to-date effective tax rate for the 2017 fiscal year is 36.7%, a decrease over the prior-year period. As a result, our profits are benefiting from an increase in operating income from jurisdictions with lower tax rates outside the United States. We anticipate that our full year tax rate will be between 36% and 37%, with a bias toward the lower end of this range.

#### Health Services Segment

The Health Services Segment provides a variety of business process services, appeals and assessments as well as related consulting services, for state, provincial and national government programs. These services support a variety of government health benefit programs including Medicaid, the Children's Health Insurance Program (CHIP) and the Affordable Care Act (ACA) in the U.S., Health Insurance BC (British Columbia) in Canada, and the Health Assessment Advisory Service (HAAS) and Fit for Work Service in the U.K.

*(dollars in thousands)*

|  | Three Months Ended December 31, 2016 | 2015 |
| --- | ---: | ---: |
| Revenue | $340,729 | $291,903 |
| Cost of revenue | 262,495 | 239,931 |
| Gross profit | 78,234 | 51,972 |
| Operating income | 50,127 | 26,808 |
| Gross profit percentage | 23.0% | 17.8% |
| Operating margin percentage | 14.7% | 9.2% |

Changes in revenue, cost of revenue and gross profit for the three months ended December 31, 2016 are summarized below.

*(dollars in thousands)*

|  | Revenue Dollars | Percentage change | Cost of Revenue Dollars | Percentage change | Gross Profit Dollars | Percentage change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Balance for respective period in fiscal year 2016 | $291,903 |  | $239,931 |  | $51,972 |  |
| Organic growth | 56,200 | 19.3% | 29,921 | 12.5% | 26,279 | 50.6% |
| Acquired growth | 6,067 | 2.1% | 4,995 | 2.1% | 1,072 | 2.1% |
| Currency effect compared to the prior period | (13,441) | (4.6)% | (12,352) | (5.1)% | (1,089) | (2.1)% |
| Balance for respective period in fiscal year 2017 | $340,729 | 16.7% | $262,495 | 9.4% | $78,234 | 50.5% |

Revenue for the three month period ended December 31, 2016 increased by 17% compared to the same period in fiscal year 2016. Cost of revenue also increased by 9.4%. The principal driver of both revenue and cost of revenue are from our United States-based businesses and the expansion of existing contracts, including the increased scope of work with New York State. The HAAS contract also provided revenue growth and gross profit expansion in the quarter. Most of the currency effect in this period relates to the HAAS contract which was affected by the devaluation of the British Pound. We acquired Ascend in February 2016 and, accordingly, our results for fiscal year 2017 will include the benefit of this acquired growth.

During the first quarter of fiscal year 2016, revenue and profit were unfavorably impacted, due in large part, by the delay of a change order where we had performed work and incurred the costs prior to the related contract amendment being signed. Costs related to this amendment were incurred in the first quarter of last year but approximately $8.6 million of revenue could not be recognized until the second quarter of fiscal 2016 when the amendment was signed. Although we work "at risk" from time-to-time, the revenue deferred from this arrangement was material to our financial results. If this amendment had been signed prior to the quarter end, our gross and operating profit margins would have been 20.2% and 11.8%, respectively. In addition, the HAAS contract which commenced in fiscal year 2015 and faced performance challenges early on, also tempered margins in the first quarter of fiscal 2016.

#### U.S. Federal Services Segment

The U.S. Federal Services Segment provides business process solutions, program management, as well as system development and software development for various civilian U.S. federal programs.

*(dollars in thousands)*

|  | Three Months Ended December 31, 2016 | 2015 |
| --- | ---: | ---: |
| Revenue | $141,298 | $145,285 |
| Cost of revenue | 103,722 | 117,047 |
| Gross profit | 37,576 | 28,238 |
| Operating income | 17,881 | 10,716 |
| Gross profit percentage | 26.6% | 19.4% |
| Operating margin percentage | 12.7% | 7.4% |

Revenue for the three month period ended December 31, 2016 decreased $4.0 million, or 2.7%, compared to the same period in fiscal year 2016. The corresponding decline in cost of revenue was $13.3 million, or 11%. This resulted in an increase to our gross profit, operating income and profit margins. All revenue, cost and profit movement between periods is organic.

We had previously anticipated that the U.S. Federal Segment would be affected by lower volumes on a large healthcare contract for the U.S. Veteran's Administration where we are a subcontractor. This decline for the first quarter of fiscal year 2017 was in line with expectations and resulted in a significant reduction in revenue. This was offset by improvements in numerous other contracts.

A reduction in costs and temporary spike in volumes on a couple of transaction-based contracts helped improve gross profit margin. We have instituted business optimization efficiencies including the increased use of technology and the reduced use of subcontractors. These efficiencies should recur in future quarters.

The aforementioned subcontract with the Veteran's Administration is now expected to end in Spring 2017 due to insufficient volumes. As a result we currently anticipate that the U.S. Federal Segment will experience an organic revenue decline for the full year of fiscal 2017 compared to fiscal 2016, unless this revenue is backfilled with new work.

#### Human Services Segment

The Human Services Segment provides national, state and county human services agencies with a variety of business process services and related consulting services for welfare-to-work, child support, higher education institutions and other Human Services programs. About 66% of our revenue in this segment is earned in foreign jurisdictions.

*(dollars in thousands)*

|  | Three Months Ended December 31, 2016 | 2015 |
| --- | ---: | ---: |
| Revenue | $125,537 | $119,534 |
| Cost of revenue | 96,529 | 89,529 |
| Gross profit | 29,008 | 30,005 |
| Operating income | 11,769 | 9,107 |
| Gross profit percentage | 23.1% | 25.1% |
| Operating margin percentage | 9.4% | 7.6% |

16

Changes in revenue, cost of revenue and gross profit for the three months ended December 31, 2016 are summarized below.

*(dollars in thousands)*

|  | Revenue Dollars | Percentage change | Cost of Revenue Dollars | Percentage change | Gross Profit Dollars | Percentage change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Balance for respective period in fiscal year 2016 | $119,534 |  | $89,529 |  | $30,005 |  |
| Organic growth | 7,974 | 6.7% | 8,180 | 9.1% | (206) | (0.7)% |
| Acquired growth | 312 | 0.3% | 575 | 0.6% | (263) | (0.9)% |
| Currency effect compared to the prior period | (2,283) | (1.9)% | (1,755) | (2.0)% | (528) | (1.8)% |
| Balance for respective period in fiscal year 2017 | $125,537 | 5.0% | $96,529 | 7.8% | $29,008 | (3.3)% |

Revenue for the three month period ended December 31, 2016 increased 5.0% compared to the same period in fiscal year 2016. Revenue growth was principally due to by our jobactive contract in Australia that is now fully ramped. This was offset by expected decreases from U.K as the Work Programme contract begins to wind down. Our U.K. business has also been adversely impacted by the decline in the value of the British Pound.

Costs of revenue increased by 7.8%, resulting in a decline in the gross profit margin. Our gross profit margin declined principally due to the U.K. Work Programme contract which is coming to an end.

### Liquidity and Capital Resources

Our principal source of liquidity remains our cash flows from operations. These operating cash flows are used to fund our ongoing operations and working capital needs as well as investments in capital infrastructure and share repurchases. Cash flows from operations are driven by our contracts and their payment terms. For some contracts, we are reimbursed for the costs of start-up operations, although there may be a gap between incurring and receiving these funds. Other factors which may cause shortfalls in cash flows include contract terms where payments are tied to outcome deliveries, which may not correspond with the costs incurred to achieve these outcomes and short-term delays where government budgets are constrained.

To supplement our cash flows from operations, we also use a credit facility. We used this facility to fund our acquisitions, as well as short-term borrowings to cover immediate working capital needs. At December 31, 2016, we had outstanding borrowings of $149.7 million under the credit facility. Our credit facility allows us to borrow up to $400 million, subject to standard covenants. We anticipate that our cash flows from operations should be sufficient to meet our day-to-day requirements, as well as pay our interest and repay the principal on our existing borrowings.

At December 31, 2016, our foreign subsidiaries held $66.6 million of our cash and cash equivalents. We have no requirement or intent to remit this cash to the United States. We consider undistributed earnings of our foreign subsidiaries to be indefinitely reinvested outside of the United States and, accordingly, no U.S. deferred taxes have been recorded with respect to such earnings in accordance with the relevant accounting guidance for income taxes. Should the earnings be remitted as dividends, we may be subject to additional U.S. taxes, net of allowable foreign tax credits. It is not practicable to estimate the amount of any additional taxes that may be payable on the undistributed earnings given the various tax planning alternatives we could employ, should we decide to repatriate these earnings in a tax-efficient manner.

#### Cash Flows

The following table provides a summary of our cash flow information for the three months ended December 31, 2016 and 2015.

*(dollars in thousands)*

| Net cash provided by/(used in): | Three Months Ended December 31, 2016 | 2015 |
| --- | ---: | ---: |
| Operations | $71,140 | $1,366 |
| Investing activities | (7,340) | (13,207) |
| Financing activities | (57,154) | (11,283) |
| Effect of exchange rate changes on cash and cash equivalents | (3,078) | (590) |
| Net increase/(decrease) in cash and cash equivalents | $3,568 | $(23,714) |

Cash flows from operations were $71.1 million for the three months ended December 31, 2016, compared to $1.4 million in the prior fiscal year. Our increase in cash flows were driven by:

- Improvements in our profitability;
- Delays in payments at December 31, 2015 from two customers in the United States, which were subsequently resolved; and
- Timing for income tax payments.

We use the performance indicator of Days Sales Outstanding, or DSO, to evaluate our performance in collecting our receivable balances. At December 31 and September 30, 2016, our DSO were 70 days, compared with 75 days at December 31, 2015. An improvement of five days might be expected to improve cash flows by approximately $33 million.

Cash used in investing activities for the three months ended December 31, 2016 was $7.3 million. Cash flows in the comparative period had been affected by significant investment in Australia, for the jobactive contract, as well as the acquisition of Assessments Australia for $2.6 million. As anticipated, our capital expenditures have returned to lower levels. Our cash flows in fiscal year 2017 included $0.4 million as part of the settlement of the sale price of our K-12 Education business.

Cash flows from financing activities in the three months ended December 31, 2016 include cash payments to pay dividends, repurchase our common stock and settle our employees income tax obligations from net settlement of RSUs which vested in September. These payments related to our equity totaled $40.9 million and $45.6 million, for the first quarters of fiscal years 2017 and 2016, respectively. During fiscal year 2017, we made net debt repayments of $15.1 million, compared with net borrowings of $34.3 million in the comparative period. Our borrowings in the first quarter of fiscal year 2016 were driven by the growth in DSOs.

The detrimental effect of exchange rates on cash and cash equivalents of $3.1 million in the 2016 fiscal year primarily reflects the strengthening of the United States Dollar against the Australian Dollar and British Pound.

To supplement our statements of cash flows presented on a GAAP basis, we use the measure of free cash flow to analyze the funds generated from operations.

*(dollars in thousands)*

|  | Three Months Ended December 31, 2016 | 2015 |
| --- | ---: | ---: |
| Cash flows from operations | $71,140 | $1,366 |
| Purchases of property and equipment and capitalized software costs | (7,768) | (10,685) |
| Free cash flow | $63,372 | $(9,319) |

18

### Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenue and expenses. On an ongoing basis we evaluate our estimates, including those related to revenue recognition and cost estimation on certain contracts, the realizability of goodwill and other long-lived assets, and amounts related to contingencies and income tax liabilities. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.

During the three months ended December 31, 2016, there were no significant changes to the critical accounting policies we disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s Annual Report on Form 10-K for the year ended September 30, 2016 which was filed with the Securities and Exchange Commission on November 21, 2016.

### Non-GAAP measures

We utilize non‑GAAP measures where we believe it will assist the user of our financial statements in understanding our business. The presentation of these measures is meant to complement, but not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as an alternative to revenue growth, cash flows from operations or net income as measures of performance. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.

During fiscal year 2016, we acquired Ascend and Assessments Australia and disposed of our K-12 Education business. We believe users of our financial statements wish to evaluate the performance of our underlying business, excluding changes that have arisen due to businesses acquired or disposed of. We provide organic revenue growth as a useful basis for assessing this. To calculate organic revenue growth, we compare current year revenue excluding revenue from these acquisitions to our prior year revenue.

In fiscal year 2016, 28% of our revenue was generated outside the U.S. We believe that users of our financial statements wish to understand the performance of our foreign operations using a methodology which excludes the effect of year-over-year exchange rate fluctuations. To calculate year-over-year currency movement, we determine the current year’s results for all foreign businesses using the exchange rates in the prior year.

In order to sustain our cash flows from operations, we require regular refreshing of our fixed assets and technology. We believe that users of our financial statements wish to understand the cash flows that directly correspond with our operations and the investments we must make in those operations using a methodology which combines operating cash flows and capital expenditures. We provide free cash flow to complement our statement of cash flows. Free cash flow shows the effects of the Company’s operations and routine capital expenditures and excludes the cash flow effects of acquisitions, share repurchases, dividend payments and other financing transactions. We have provided a reconciliation of free cash flow to cash flows from operations.

To sustain our operations, our principal source of financing comes from receiving payments from our customers. We believe that users of our financial statements wish to evaluate our efficiency in converting revenue into cash receipts. Accordingly, we provide DSO, which we calculate by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 91 days.

Our credit agreement includes the defined term Consolidated EBITDA and our calculation of Adjusted EBITDA conforms to the credit agreement definition. We believe our investors appreciate the opportunity to understand the possible restrictions which arise from our credit agreement. Adjusted EBITDA is also a useful measure of performance which focuses on the cash generating capacity of the business as it excludes the non-cash expenses of depreciation and amortization, and makes for easier comparisons between the operating performance of companies with different capital structures by excluding interest expense and therefore the impacts of financing costs. The measure of Adjusted EBITA is a step in calculating Adjusted EBITDA and facilitates comparisons to similar businesses as it isolates the amortization effect of business combinations. We have provided a reconciliation from net income to Adjusted EBITA and Adjusted EBITDA below. Our credit agreement requires us to utilize

Adjusted EBITDA on a trailing twelve month basis to calculate conformity with covenants and other restrictions; in particular, a debt-to-EBITDA ratio exceeding 2.5:1.0 would require us to provide security for the borrowings; a debt-to-EBITDA ratio in excess of 3.5:1.0 would represent a violation of our debt agreement. Our debt-to-EBITDA ratio was below 1.0:1.0 for all periods presented. We have included our calculations of EBITDA below.

*(dollars in thousands)*

|  | Three Months Ended December 31, 2016 | 2015 | Trailing Twelve Months Ended December 31, 2016 | 2015 |
| --- | ---: | ---: | ---: | ---: |
| Net income attributable to MAXIMUS | $46,664 | $26,609 | $198,417 | $142,520 |
| Net interest expense | 746 | 800 | 3,412 | 2,009 |
| Provision of income taxes | 26,861 | 16,046 | 116,623 | 92,034 |
| Amortization of intangible assets | 3,402 | 3,149 | 13,630 | 11,023 |
| Stock compensation expense | 4,889 | 4,332 | 19,308 | 17,603 |
| Acquisition-related expenses | — | 46 | 786 | 4,191 |
| Gain on sale of a business | — | — | (6,880) | — |
| Adjusted EBITA | 82,562 | 50,982 | 345,296 | 269,380 |
| Depreciation and amortization of property, plant, equipment and capitalized software | 14,562 | 12,947 | 60,019 | 48,829 |
| Adjusted EBITDA | $97,124 | $63,929 | $405,315 | $318,209 |

20

## Market risk

As filed, 1,628 characters.

Our exposure to market risks generally relates to changes in interest rates and foreign currency exchange rates.

We are exposed to market rate risk on interest rates through our revolving credit facility. Our cash equivalent balances are held in highly rated securities with maturities of three months or less. We manage our exposure to interest rate fluctuations through the use of interest rate swap agreements. At December 31, 2016, we had borrowings under our credit facility of $149.7 million and we had an interest rate swap agreement fixing a notional $28.0 million of this balance. Our interest rate varies based upon our leverage, as defined in our agreement with our lenders, but we are currently paying interest at a rate based upon the one-month London Interbank Offering Rate (LIBOR) plus 1%. The one-month LIBOR rate at December 31, 2016 was 0.77%. A hypothetical increase in LIBOR by 10% would increase our annual interest expense and cash flows on our outstanding balance by $0.1 million.

We are exposed to foreign currency exchange risk through our businesses in the United Kingdom, Australia and Canada. At December 31, 2016, we held net assets in functional currencies other than the U.S. Dollar of $200.5 million and, accordingly, in the event of a 10% fluctuation in the value of the local currencies, we would report a $20.5 million gain or loss in our statement of comprehensive income. Our foreign-based businesses mitigate their currency risks through incurring costs in the same currency as their revenue. The operations of the U.S. business do not depend upon cash flows from the foreign businesses.

## Controls and procedures

As filed, 1,546 characters.

(a) Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that these disclosure controls and procedures were effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 532 characters.

In connection with information set forth in this Form 10-Q, the factors discussed under “Risk Factors” in our Form 10-K for fiscal year ended September 30, 2016 should be considered. The risks included in the Form 10-K could materially and adversely affect our business, financial condition and results of operations. There have been no material changes to the factors discussed in our Annual Report on Form 10-K for the year ended September 30, 2016 which was filed with the Securities and Exchange Commission on November 21, 2016.

Filed Feb 9, 2017.
Source: SEC EDGAR, the filing index for accession 0001032220-17-000007. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.
